Insider · SEC Form 4 filer
Douglas Garis
Past buys: 2 of 3 beat
Companies
Where they file as an insider
Claritev (CTEV) Evp&cfo Latest filing Sep 21, 2026
Track record
Did their buys beat the typical stock?
Open-market buys9
Quarters checked 6 months later3
Beat the typical stock 2 of 3
Quarters too new to check0
2 of 3 checked quarters beat the typical stock. A past record is data, not a forecast.
Claritev (CTEV) Bought Mar 16, 2026 · $23K · 1,300 shares Beat typical Mar 31, 2026 $16.34 → Sep 30, 2026 $21.17 · +29.6% (typical stock +1.7%)
Claritev (CTEV) Bought May 12–19, 2025 · $732K · 32,349 shares Behind typical Jun 30, 2025 $45.13 → Dec 31, 2025 $42.75 · −5.3% (typical stock +2.1%)
Claritev (CTEV) Bought Mar 7, 2025 · $176K · 8,919 shares Beat typical Mar 31, 2025 $20.63 → Sep 30, 2025 $53.08 · +157.3% (typical stock +7.3%)
MultiPlan (MPLN) Bought Aug 6, 2024 · $346K · 1.15M shares Not counted Not counted. We have no fund price for this stock on both Sep 30, 2024 and Mar 31, 2025.
Each row is one stock in one quarter, however many buys it took. We take the stock's price at the end of that quarter and again 6 months later, and compare it with the typical stock over the same dates. Prices are quarter-end values from funds' 13F reports (the middle value across 3 or more funds), through Sep 30, 2026. Moves past 3 times up or down, mostly stock splits, are left out. How we tested this.
Past results. This is data, not advice.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.